MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, XERS has $392,013K in assets. $379,002K in debts. $111,750K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
212.22%
Quick Ratio
149.63%
Cash Ratio
94.23%
Debt to Asset Ratio
96.68%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Intangible Assets Net Excluding ...
    • Trade accounts receivable, net
    • Others
Liabilities Breakdown
    • Additional paid in capital
    • Accumulated deficit
    • Debt, net of unamortized debt is...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
111,750 111,042 91,598 59,285
Trade accounts receivable, net
56,295 51,050 53,751 53,048
Inventory, net
74,234 68,673 67,462 67,282
Prepaid expenses and other current assets
9,403 9,548 11,206 5,963
Total current assets
251,682 240,313 224,017 185,578
Property and equipment, net
5,033 4,945 4,946 5,284
Operating lease right-of-use assets
21,949 22,112 22,263 22,403
Goodwill
22,859 22,859 22,859 22,859
Intangible Assets Net Excluding Goodwill
85,368 88,078 90,789 93,500
Other Assets Noncurrent
5,122 5,220 5,317 5,062
Total assets
392,013 383,527 370,191 334,686
Current portion of long-term debt
-0 0 0
Accounts payable
11,467 3,076 6,527 9,462
Current operating lease liabilities
6,271 6,232 6,194 6,156
Other accrued liabilities
32,287 33,155 30,350 24,969
Accrued trade discounts and rebates
45,492 43,253 51,264 33,169
Accrued returns reserve
18,723 18,969 19,216 19,782
Other current liabilities
4,353 4,889 2,649 1,633
Total current liabilities
118,593 109,574 116,200 95,171
Debt, net of unamortized debt issuance costs, non-current portion
221,224 220,335 219,469 218,626
Non-current operating lease liabilities
31,058 31,531 31,991 32,441
Other liabilities
8,127 8,398 3,392 7,752
Total liabilities
379,002 369,838 371,052 353,990
Common stockpar value 0.0001, 350,000,000 shares authorized as of march 31, 2026 and december 31, 2025 172,558,783 and 166,215,410 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively
18 17 17 16
Additional paid in capital
682,090 685,004 681,535 663,713
Accumulated deficit
-669,073 -671,307 -682,388 -683,009
Accumulated other comprehensive loss
-24 -25 -25 -24
Total stockholders' equity
13,011 13,689 -861 -19,304
Total liabilities and stockholders' equity
392,013 383,527 370,191 334,686
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$111,750K Inventory, net$74,234K Trade accountsreceivable, net$56,295K Prepaid expenses andother current assets$9,403K Total current assets$251,682K Intangible Assets NetExcluding Goodwill$85,368K Goodwill$22,859K Operating leaseright-of-use assets$21,949K Other AssetsNoncurrent$5,122K Property and equipment,net$5,033K Total assets$392,013K Total liabilities andstockholders' equity$392,013K Total liabilities$379,002K Total stockholders'equity$13,011K Accumulated deficit-$669,073K Accumulated othercomprehensive loss-$24K Debt, net ofunamortized debt issuance...$221,224K Total currentliabilities$118,593K Non-current operating leaseliabilities$31,058K Other liabilities$8,127K Additional paid in capital$682,090K Common stockpar value0.0001, 350,000,000...$18K Accrued trade discountsand rebates$45,492K Other accruedliabilities$32,287K Accrued returns reserve$18,723K Accounts payable$11,467K Current operating leaseliabilities$6,271K Other currentliabilities$4,353K

Xeris Biopharma Holdings, Inc. (XERS)

Xeris Biopharma Holdings, Inc. (XERS)